EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

22 | Early-cogn^3: smart digital solutions for early treatment of cognitive disability

Segreteria SIGOT

Geriatric Care · 11.06.2026 · 12 (s1)

DOI: 10.4081/gc.2026.15773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geriatric Care, online erschienen am 11.06.2026. Verfasst von Segreteria SIGOT. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Healthy cognitive functioning is a primary component of well-being, independence, and successful aging. Cognitive deficits can arise from various conditions, such as brain injury, mental illness, and neurological disorders. Rehabilitation is a specialized service limited to patients with access to institutional settings. In response to this unmet need, telehealth solutions are ideal for triggering the migration of care from clinics to patients’ homes.

Objectives

This project aims to: 1) test the efficacy of a digital health at-home intervention (tele@cognitive) compared to unstructured cognitive at-home rehabilitation (Active Control Group, ACG) in subjects with Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs), and Parkinson’s Disease (PD); 2) investigate the effects of tele@cognitive on biomolecular and neurophysiological markers; 3) analyze cognitive, neurobiological and neurophysiological predictors of treatment response. Materials and Methods. This multicenter, single-blind randomized controlled pilot study will include 60 participants with MCI, SCCs, and PD. Subjects will be randomized to tele@cognitive or ACG. Clinical and neuropsychological assessments will be conducted at baseline (T0), post-treatment (5 weeks, T1) and 3-month follow-up (T2). Neurophysiological (Transcranial Magnetic Stimulation, TMS) and biomolecular data will be collected at T0 and T1.

Results

We hypothesize that tele@cognitive treatment will yield significant benefits than ACG in cognitive performance, global functioning, and well-being, with measurable neurobiological effects.

Conclusions

This project could lead to a paradigm shift from the traditional therapeutic approach, forcing a reassessment on how CNDs could take advantage of a digital solution. This research was funded by the European Union—Next Generation EU—PNRR M6C2—Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN (PNRR-MCNT2-2023-12377069; CUP=C83C24000200007).

Zitieren

APA

SIGOT, S. (2026). 22 | Early-cogn^3: smart digital solutions for early treatment of cognitive disability. Geriatric Care, 12(s1). https://doi.org/10.4081/gc.2026.15773

Vancouver

SIGOT S. 22 | Early-cogn^3: smart digital solutions for early treatment of cognitive disability. Geriatric Care. 2026;12(s1). doi:10.4081/gc.2026.15773

BibTeX
@article{SIGOT2026,
  author = {SIGOT, Segreteria},
  title = {22 | Early-cogn^3: smart digital solutions for early treatment of cognitive disability},
  journal = {Geriatric Care},
  year = {2026},
  volume = {12},
  number = {s1},
  doi = {10.4081/gc.2026.15773}
}
Kostenlos starten →